Aileron Therapeutics Inc. (ALRN)

NASDAQ: ALRN · Real-Time Price · USD

2.11

0.18 (9.33%)

At close: Jan 10, 2025, 9:00 PM

Aileron Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-15.73M	-27.33M	-26.16M	-21.16M	-29.37M	-31.55M	-22.6M	-18.12M
Depreciation & Amortization	119K	169K	121K	163K	155K	218K	129K	232K
Stock-Based Compensation	1.19M	2.08M	2.26M	1.89M	2.12M	3.28M	1.75M	688K
Other Working Capital	-399K	-90K	628K	-1.4M	1.13M	246K	599K	-520K
Other Non-Cash Items	-4K	-208K	-213K	-95K	-226K	-253K	-11K	-18K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	-152K	1.51M
Change in Working Capital	-5.38M	420K	242K	-1.28M	850K	376K	358K	695K
Operating Cash Flow	-19.81M	-24.86M	-23.75M	-20.48M	-26.47M	-27.93M	-20.53M	-15.01M
Capital Expenditures	n/a	n/a	-157K	-5K	-151K	-4.42M	-142K	n/a
Cash Acquisitions	-96K	n/a	66K	208K	2.66K	n/a	n/a	n/a
Purchase of Investments	n/a	-21.85M	-73.58M	-10.03M	-27.24M	-31.19M	-71.06M	-12.63M
Sales Maturities Of Investments	16.25M	48.31M	37.75M	16.24M	24.57M	60.3M	32.29M	12.63M
Other Investing Acitivies	42K	26.46K	-35.76K	6.42K	-2.66K	29.11M	-38.77M	-25K
Investing Cash Flow	16.2M	26.46M	-35.92M	6.41M	-2.81M	24.69M	-38.91M	-25K
Debt Repayment	n/a	n/a	n/a	387K	n/a	2.47M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.79M	n/a	74K	n/a	165K	42K	-2.19M	-157K
Financial Cash Flow	15.79M	n/a	55.66M	15.8M	23.96M	2.52M	50.59M	31.99M
Net Cash Flow	12.12M	1.59M	-4.01M	1.74M	-5.32M	-723K	-8.85M	16.95M
Free Cash Flow	-19.81M	-24.86M	-23.91M	-20.48M	-26.63M	-32.35M	-20.67M	-15.01M